Diskussionsleiter: D. Thomas (Heidelberg)
| (P1702) | Expiration-triggered sinus arrhythmia predicts outcome in survivors of acute myocardial infarction | |
| D. Sinnecker, M. Dommasch, A. Steger, P. Barthel, K.-L. Laugwitz, G. Schmidt (München) | ||
| (P1703) | Association of cardiac biomarkers with QT interval: insights from the LIFE-Adult-Study | |
| J. Kornej, M. Loeffler, J. Thiery, R. Burkhardt, R. Baber, A. Bollmann, C. Engel, D. Husser-Bollmann (Leipzig) | ||
| (P1704) | Comparison of the electrophysiologic effects of vernakalant and ranolazine in an experimental whole-heart model of atrial fibrillation | |
| G. Frommeyer, C. Ellermann, M. Sterneberg, D. Dechering, S. Kochhäuser, F. Reinke, P. Milberg, L. Eckardt (Münster) | ||
| (P1705) | Interactions of digitalis and class-III antiarrhythmic drugs: amiodarone versus dronedarone | |
| G. Frommeyer, C. Ellermann, D. Puckhaber, D. Dechering, S. Kochhäuser, F. Reinke, C. Pott, L. Eckardt (Münster) | ||
| (P1706) | QTc interval evaluation after left bundle branch block correction in heart failure patients: first results of a prospective multicenter study | |
| C. Gemein, D. Erkapic, P. Conzen, E. Pechlivanidou, K. Weipert, I. M. Helmig, R. Chasan, V. Johnson, G. Frommeyer, C. W. Hamm, B. Lemke, J. Schmitt, M. Zarse, H. Bogossian (Gießen, Lüdenscheid, Münster) | ||
| (P1707) | Divergent proarrhythmic potential of fluconazole and voriconazole in an experimental whole-heart model | |
| G. Frommeyer, C. Fischer, P. Leitz, P. S. Lange, H. Bogossian, P. Milberg, L. Eckardt (Münster, Lüdenscheid) |